| Specialty Retail Industry | Consumer Discretionary Sector | Ms. Melissa Josephine Sturgess BSc, MBA CEO | XSTU Exchange | - ISIN |
| United Kingdom Country | 9 Employees | - Last Dividend | - Last Split | - IPO Date |
Ananda Developments Plc is a pioneering entity in the field of medicinal and therapeutic cannabis, focusing its efforts on the investment and development of solutions within this emerging market. Established in 2018 and headquartered in London, the United Kingdom, the company strives to leverage the therapeutic potentials of cannabinoids. Ananda Developments is dedicated to creating innovative cannabinoid-based medicines designed specifically to address chronic inflammatory pain conditions, an area of significant unmet medical need. Through its strategic investments and research initiatives, the company aims to be at the forefront of delivering effective, cannabis-based therapeutic options to patients, tapping into a market driven by increasing recognition of cannabis's medicinal benefits.
Ananda Developments is focused on the discovery and development of medicines derived from cannabinoids. These medicines are intended for the treatment of chronic inflammatory pain conditions, providing an alternative to traditional pain management solutions. The company employs scientific methods to explore the efficacy and safety of cannabinoids, with the goal of producing pharmaceutical-grade products that meet rigorous medical standards.